AVITA Medical (RCEL) Cash from Operations Growth (3y) (2022 - 2025)
AVITA Medical (RCEL) Cash from Operations Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 9.30% |
| 10 | AVITA Medical | 309.50 Mn | 298.36 Mn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40.85% |
| Mar 31, 2025 | -3.23% |
| Sep 30, 2024 | 18.09% |
| Jun 30, 2024 | -0.64% |
| Mar 31, 2024 | -34.68% |
| Dec 31, 2023 | -24.16% |
| Sep 30, 2023 | -5.18% |
| Mar 31, 2023 | -7.54% |
| Dec 31, 2022 | 51.41% |